Study of Eyes and Attention Deficit (SEAD)

ADHD Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00472511
• Other study ID #: 2001H0269
• Status: Completed
• Phase: N/A
• First received: May 9, 2007
• Last updated: July 1, 2008

Study information

• Verified date: July 2008
• Source: Ohio State University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Attention-Deficit Hyperactivity Disorder (ADHD) is considered to be one of the most prevalent chronic health conditions in children. It affects between 4% and 12% of young children. A relationship between convergence insufficiency (eye teaming) and ADHD has been shown. However, the effect of ADHD medications on focusing and eye teaming has not been previously investigated. Therefore, the purpose of this study is to determine the effect of ADHD medication on focusing and eye teaming skills.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 7 Years to 18 Years

Eligibility

Inclusion Criteria:

• Best corrected visual acuity of 20/25 in both eyes at distance and near;

• Willingness to wear eyeglasses or contact lenses to correct refractive error, if necessary;

• 500" random dot stereopsis

Exclusion Criteria:

• Amblyopia (lazy eye);

• Eye disease

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Accommodative Insufficiency
• ADHD
• Convergence Insufficiency
• Ocular Motility Disorders

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Ohio State University